histone acetyltransferase activators (Columbia University/Columbia Technology Ventures)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehistone acetyltransferase activators (Columbia University/Columbia Technology Ventures)
Drug Alias NameHAT activators (Columbia University/Columbia Technology Ventures)YF-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferases stimulants
TargetsHistone acetyltransferases
Therapy Area/IndicationsNerve DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNerve DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A